Standard diagnostic and therapeutic process of HCV chronic infection


Authors: P. Urbánek;  P. Husa;  J. Galský;  J. Šperl;  V. Hejda;  P. Kümpel;  V. Němeček;  S. Plíšek;  M. Volfová
Authors‘ workplace: Pracovní skupina pro virové hepatitidy České hepatologické společnosti ČLS JEP, Pracovní skupina pro virové hepatitidy Společnosti infekčního lékařství ČLS JEP
Published in: Gastroent Hepatol 2012; 66(3): 214-229
Category: Hepatology: Best Practises


Sources

1. European Association for the Study of the Liver: EASL Clinical Practice Guidelines: Management of hepatitis C virus infection. J Hepatol 2011; 55(2): 245–264.

2. Ghany MG, Nelson DR, Strader DB et al. An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Asso­ciation for the Study of Liver Diseases. Hepatology 2011; 54(4): 1433–1444.

3. Poordad F, McCone J Jr., Bacon BR et al. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011; 364(13): 1195–1206.

4. Jacobson IM, McHutchison JG, Dus­heiko G et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011; 364(25): 2405–2416.

5. Sherman KE, Flamm SL, Afdhal NH et al. Response-guided telaprevir combination treatment for hepatitis C virus infection. N Engl J Med 2011; 365(11): 1014–1024.

6. Bacon BR, Gordon SC, Lawitz E et al. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med 2011; 364(13): 1207–1217.

7. Zeuzem S, Andreone P, Pol S et al. Telaprevir for retreatment of HCV infection. N Engl J Med 2011; 364(25): 2417–2428.

8. Strader DB, Wright T, Thomas DL et al. Diagnosis, Management, and treatment of hepatitis C. AASLD Practice Guideline. ­Hepatology 2004; 39(4): 1147–1171.

9. Manns MP, McHutchison JG, Gordon SC et al. PEG-interferon alfa-2b in combination with ribavirin compared to interferon alfa 2b plus ribavirin for initial treatment of chronic hepatitis C. Lancet 2001; 358(9286): 958–965.

10. Fried MW, Shiffman ML, Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975–982.

11. Hadziyannis SJ, Sette H, Morgan TR et al. Peginterferon alfa-2a (40 kilodaltons) and ribavirin combination therapy in chronic hepatitis C: randomized study of the effect of treatment duration and ribavirin dose. Ann Intern Med 2004; 140(5): 346–355.

12. Zeuzem S, Buti M, Ferenci P et al. Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia. J Hepa­tol 2006; 44(1): 97–103.

13. Zeuzem S, Pawlotsky J-M, Lukasiewicz E et al. International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C. J Hepatol 2005; 43(2): 250–257.

14. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47(RR-19): 1–39.

15. Hu J, Doucette K, Hartling L et al. Treatment of Hepatitis C in Children: A Systematic Review. PLoS One 2010; 5(7): e11542.

16. Schwarz KB et al. Peginterferon with or without ribavirin for chronic hepatitis C in children and adolescents: final results of the PEDS-C trial. Hepatology 2008; 48 (4 Suppl): 418A.

17. Wirth S et al. Children with HCV infection show high sustained virologic response on peginterferon alfa-2b plus ribavirin treatment. Hepatology 2008; 48 (4 Suppl): 392A.

18. Wirth S, Ribes-Kominckx C, Calzado MA et al. High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin. J Hepatol 2010; 52(4): 501–507.

Labels
Paediatric gastroenterology Gastroenterology and hepatology Surgery

Article was published in

Gastroenterology and Hepatology

Issue 3

2012 Issue 3

Most read in this issue
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account